SDI
SDI FPO [SDI]
Healthcare · ASX Small Cap
$1.2800 +44.6%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 3 consecutive scans→ Score -1First seen: 2026-02-25
Score Breakdown
Technical55
Catalyst50
Sentiment50
Fundamental90
Momentum66
Risk Gate50
Active Signals
Bullish Signals
- MACD momentum strengthening
- Sustained volume spike (4.1x median) on DOWN trend
- Breakout above 20-day resistance
- Strong 5-day momentum (+42.2%)
- Volatility expanding rapidly (choppy)
- Above 200-day MA (long-term uptrend)
- Cash positive / operating cashflow positive
- Low P/S ratio (1.0x)
- Piotroski F-Score strong (8/9)
- EPS estimates revised upward (+6pts)
- CANSLIM C: Positive EPS growth (24% QoQ)
- CANSLIM S: Tight float (37%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE2 (est. 2021-03-31)
Risk Signals
- RSI overbought (caution)
- Price at upper Bollinger Band (overbought)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE SDI Enters into a Scheme Implementation Deed
NONE Appendix 4D Dcember 2025
MEDIUM Trading Update December 2025
Recent ASX Announcements
| 2026-02-27 | SDI Enters into a Scheme Implementation Deed PRICE SENSITIVE |
| 2026-02-27 | Appendix 4D Dcember 2025 PRICE SENSITIVE |
| 2026-01-06 | Trading Update December 2025 PRICE SENSITIVE |
Key Metrics
$105.2M
Market Cap
115K
Avg Volume
4.1x
Vol Ratio
$0.80 — $1.02
52-Week Range
N/A
Short Interest
N/A
Cash Runway
12.4%
ROE
11.0%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | weak | EPS Growth: 24% |
| A | Annual Earnings | neutral | CAGR: 5% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 37% |
| L | Leader vs Laggard | pass | RS: 7 |
| I | Institutional Sponsorship | weak | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #6 of 119 · Sector avg: 51
View all Healthcare signals →